Pancreatic Drug Resistance Explained

Researchers find that patients eventually develop resistance to daraxonrasib, a drug for pancreatic cancer. The study notes that even patients such as former Senator Ben Sasse experience this resistance. The investigation aims to uncover the mechanisms behind this drug resistance to improve future therapies.